Market Place
Sourcing Support
ADA: Novo`s Oral Wegovy Hits 3 Million Prescriptions Milestone
08 Jun 2026 //
FIERCE PHARMA
Novo Nordisk Targets 2030 Launch for Triple-G Obesity Shot
08 Jun 2026 //
ENDPOINTS
Novo Nordisk Launches Share Repurchase Programme
08 Jun 2026 //
GLOBENEWSWIRE
Wegovy Pill Surpasses 3M Prescriptions as Novo Presents ADA Data
07 Jun 2026 //
PR NEWSWIRE
Novo`s CagriSema Cuts HbA1c and Weight in REIMAGINE at ADA
07 Jun 2026 //
PR NEWSWIRE
Semaglutide 2mg Rivals Tirzepatide in HbA1c & Weight Loss in T2D
06 Jun 2026 //
PR NEWSWIRE
Novo Nordisk to Present Wegovy® Cardiometabolic Data at ADA 2026
06 Jun 2026 //
PR NEWSWIRE
Novo`s Zenagamtide Achieves 14.6% Weight Loss in T2D at ADA 2026
05 Jun 2026 //
PR NEWSWIRE
Lilly and Novo Clash at ADA 2026 as Rivals Chase Obesity Market
05 Jun 2026 //
BIOSPACE
Novo Nordisk Indiana Site Under FDA Scrutiny Again
04 Jun 2026 //
ENDPOINTS
Wegovy Pill Launches in UAE as Novo Expands Obesity Access
03 Jun 2026 //
GLOBENEWSWIRE
Obesity Davids And Goliaths Face Off At ADA 2026
01 Jun 2026 //
BIOSPACE
Novo Nordisk A/S - Share Repurchase Programme
01 Jun 2026 //
GLOBENEWSWIRE
Novo Nordisk Presents CagriSema and Zenagamtide at ADA 2026
27 May 2026 //
PR NEWSWIRE
Novo: 2 in 5 CVD Patients Have Cardiovascular Inflammation
26 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Launches Share Repurchase Programme
26 May 2026 //
GLOBENEWSWIRE
Brazil Approves First Generic Version of Ozempic
26 May 2026 //
REUTERS
CHMP Backs Oral Semaglutide as Most Efficacious GLP-1 Pill
22 May 2026 //
GLOBENEWSWIRE
CHMP Backs AZ`s Breast Cancer Drug After FDA Adcomm Rejection
22 May 2026 //
FIERCE PHARMA
CHMP Backs Wegovy 7.2 mg for Up to 20.7% Weight Loss
22 May 2026 //
GLOBENEWSWIRE
Novo Nordisk uses AI to fast-track drug launches
22 May 2026 //
REUTERS
Novo Research Chief Petersen: Streamlined R&D Speeds Discovery
19 May 2026 //
ENDPOINTS
Two Pharma Firms Own Nearly 100% of GLP-1 Citations in AI
19 May 2026 //
PR NEWSWIRE
Novo Nordisk to Unveil Semaglutide Data on Liver Disease
19 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Launches Share Repurchase Programme
18 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Data Shows Wegovy Pill Achieves 21.6% Weight Loss
13 May 2026 //
GLOBENEWSWIRE
Novo Board Members And Executives Trade Company Shares
12 May 2026 //
GLOBENEWSWIRE
Novo Nordisk: Wegovy Shows 28% Weight Loss in Early Responders
12 May 2026 //
GLOBENEWSWIRE
Rezdiffra Beats Wall Street Forecasts in MASH Market
11 May 2026 //
ENDPOINTS
Cellular Intelligence Enters Agreement Novo on Parkinson Therapy
11 May 2026 //
PR NEWSWIRE
Novo and Lilly Gain on Weight-Loss Pill Market Signals
07 May 2026 //
REUTERS
Amazon Adds Ozempic Pill To Same-Day Prescription Drug Kiosks
07 May 2026 //
ENDPOINTS
Novo Nordisk Reports DKK 32.9B Adjusted Q1 2026 Profit
06 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Launches Share Repurchase Program
05 May 2026 //
GLOBENEWSWIRE
Ozempic Maker To Pilot Diabetes, Obesity Treatments In Singapore
03 May 2026 //
FIRSTWORD PHARMA
Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes
01 May 2026 //
PR NEWSWIRE
Weight Watchers Expands Med+ With New Ozempic (Semaglutide)
01 May 2026 //
GLOBENEWSWIRE
Goodrx Adds Ozempic Pill For Type 2 Diabetes Patients
01 May 2026 //
PHARMIWEB
FDA Proposes Limits On Bulk Compounding Of Novo, Lilly
30 Apr 2026 //
REUTERS
Early sales of Lilly’s obesity pill appear to trail Novo’s
30 Apr 2026 //
ENDPOINTS
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Novo Nordisk at ECO: Wegovy & Next-Gen Weight Loss Treatments
28 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk Gets Fast Track for Coramitug in ATTR
27 Apr 2026 //
PHARMIWEB
Novo Nordisk A/S: Share Repurchase Programme
27 Apr 2026 //
GLOBENEWSWIRE
Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide
27 Apr 2026 //
FIERCE PHARMA
Lilly`s Obesity Pill Shows Modest Performance In Second Week
24 Apr 2026 //
REUTERS HEALTHCARE
MHRA Approves 48-Hour Controlled-Temp Storage for Wegovy
23 Apr 2026 //
PHARMIWEB
New Funding Paves Way for Better Diagnostics, Biosolutions
23 Apr 2026 //
GLOBENEWSWIRE
Lilly, Novo Dip on Medicare GLP-1 Coverage Pilot Uncertainty
22 Apr 2026 //
BIOSPACE
Novo`s Etavopivat Meets Both Endpoints in Sickle Cell Disease
20 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
20 Apr 2026 //
GLOBENEWSWIRE
Study Suggests Lilly`s Tirzepatide Causes More Lean Muscle Loss
17 Apr 2026 //
ENDPOINTS
Novo Nordisk weight-loss drug shows liver benefits in mouse study
16 Apr 2026 //
REUTERS
Wegovy-maker Novo Nordisk partners with OpenAI
16 Apr 2026 //
REUTERS
MHRA Approves Single-Dose Injection Device For Wegovy 7.2Mg
14 Apr 2026 //
PHARMIWEB
Pharma Gears Up For Q1 Earnings With Focus On Deals
14 Apr 2026 //
BIOSPACE
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
Novo Nordisk A/S: Share Repurchase Programme
13 Apr 2026 //
GLOBENEWSWIRE
Mounjaro Sales Decline Due To Semaglutide Generics` Rise
10 Apr 2026 //
ECONOMICTIMES
Novo`s GLP-1 Pioneer Retires; Obesity Leader Joins Boehringer
10 Apr 2026 //
ENDPOINTS NEWS
